Mission Statement: Established in 1994 as an independent organization of health care professionals concerned with the science of human sexual function and dysfunction, the Sexual Medicine Society of North America, Inc. (SMS) strives to:

• Promote, encourage, and support the highest standards of practice, research, education, and ethics in the study of the anatomy, physiology, pathology, diagnosis, and treatment of human sexual function and dysfunction and
• Provide a forum for the free exchange and discussion of new ideas, thoughts, and concepts in this field.

The SMS seeks to identify existing and emerging issues in the field of human sexual function and dysfunction, provide accurate and credible information to medical professionals, develop standards and guidelines for impotence research and practice, and produce educational program that bring leading-edge concepts of research, clinical practice, ethics, and politics to health care professionals interested in impotence and related matters.

General Disclaimer for the SMS: The opinions of the program participants are their own and do not necessarily represent those of the SMS. Participation by the guest experts and by members of the SMS, is not to imply endorsement of products and services by the SMS. Exhibition by industry does not necessarily represent endorsement of these exhibited products or services by the SMS.

Needs Statement: Sexual medicine is experiencing fast developments and progress in all areas of male and female sexual dysfunctions. These rapid developments and progress include basic sciences and clinical sciences, resulting in major advances in diagnosis, measurement, epidemiology, discovery, treatment, and prevention of sexual dysfunctions. The area of pharmacotherapy is undergoing revolutionary progress with the development and approval of new effective and safe oral drugs. In addition, surgical therapy has experienced significant innovations in prostheses and surgical techniques. A multidisciplinary diversity of health care providers care for patients with sexual dysfunctions. There is a great need to bring up to date education and broad spectrum information to health care providers confronted with large numbers of patients with sexual dysfunctions. Additionally it is important that efforts be made to provide multi-disciplinary care to patients with sexual dysfunction as part of cancer therapy.

Educational Objectives: The target audience is urologists, residents, fellows, students, researchers and all those interested in sexual medicine. This educational event will be publicized to AUA members, SMSNA members, ISSM members and affiliate societies. This meeting will present up-to-date information on male erectile dysfunction, premature ejaculation, Peyronie’s disease, priapism, hypogonadism, female sexual dysfunction and other male and female sexual dysfunctions. A special session will cover sexual dysfunction after cancer therapy and novel strategies for tissue regeneration. The information will cover many of the related fields, such as anatomy, physiology, epidemiology, pathophysiology, diagnosis, measurement, discovery, research, treatment and prevention. The participants are expected to acquire knowledge and skills for the evaluation and treatment of patients with the various sexual dysfunctions. The meeting will include state of the art lectures, debates, symposia, a workshop and an interactive session, in addition to peer reviewed podium and poster presentations.

At the conclusion of this meeting, the attendee will be able to:

1. Assess a comprehensive overview of the epidemiology, risk factors and psychosocial impact of male and female sexual dysfunction.
2. Describe the basic evaluation and management strategies for male and female sexual dysfunction in clinical practice.
3. Describe indications, techniques and complications of prosthetic surgery for male sexual dysfunction.
4. Interpret clinical trail data and investigative techniques in the management of sexual dysfunction.
5. Identify the symptoms and use appropriate tests to diagnose male hypogonadism.
6. Recognize the relationships between components of the metabolic syndrome with androgen deficiency.
7. Explain the different types of androgen replacement therapy.
8. Illustrate the use of PDE 5 inhibitors with androgens in men with sexual dysfunction.
9. Discuss the differing perspectives of oncologists, urologic oncologic surgeons, radiation oncologists, and sexual medicine experts in the field of sexual dysfunction consequent to cancer therapy.

Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The AUA takes responsibility for the content, quality, and scientific integrity of this CME activity.

Credit Designation: The American Urological Association designates this educational activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AUA Disclosure Policy: As a provider accredited by the ACCME, the AUA must ensure balance, independence, objectivity and scientific rigor in all its activities.

All faculty participating in an educational activity provided by the AUA are required to disclose to the audience any relevant financial relationships with any commercial interest to the provider. The intent of this disclosure is not to prevent faculty with relevant financial relationships from serving as faculty, but rather to provide members of the audience with information on which they can make their own judgments. The AUA must resolve any conflicts of interest prior to the commencement of the educational activity. It remains for the audience to determine if the faculty’s relationships may influence the educational content with regard to exposition or conclusion. When unlabeled or unapproved uses of drugs or devices are discussed, these are also indicated.

Unlabeled or Unapproved Use of Drugs or Devices: It is the policy of the AUA to require the disclosure of all references to unlabeled or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to unlabeled or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

Evidence Based Content: As a provider of continuing medical education accredited by the ACCME, it is the policy of the AUA to review and certify that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

Special Assistance/Dietary Needs: The American Urological Association (AUA), an organization accredited for Continuing Medical Education (CME), complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, a written request should be submitted at least one month in advance. For additional assistance with your request please call (847) 517-7225.